Activity of the growth hormone-releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis-like granuloma.
Chongxu ZhangRunxia TianEmilee M DreifusAbdolrazagh Hashemi ShahrakiGregory HoltRenzhi CaiAnthony GriswoldPablo BejaranoRobert JacksonAndrew V SchallyMehdi MirsaeidiPublished in: Clinical & translational immunology (2021)
Our findings further suggest that GHRH-R is potentially a clinical target for the treatment of granulomatous disease and that MIA602 may be used as a novel therapeutic agent for sarcoidosis.